Get the app
US › Healthcare

Biodexa Pharmaceticals (BDRX)

US · Healthcare · Biotechnology

$2.48+2.88%
Last close · 2026-11-06

Key statistics

Market cap
$1.8M
P/E
0.0
Forward P/E
0.0
P/B
0.07
Book value
$138.06
EPS (TTM)
$509.89
52-week high
$357.60
52-week low
$2.70
50-day MA
$5.58
200-day MA
$25.36
Beta
1.28

Analyst view

with an average price target of $72.12.

Shareholding

Institutions
0.37%

Largest institutional holders

FundStake
Armistice Capital, LLC0.67%
GAMMA Investing LLC0.05%
Allied Private Wealth LLC0.02%
SBI Securities Co Ltd0.00%
UBS Group AG0.00%
Hilton Head Capital Partners, LLC0.00%
Caitong International Asset Management Co., Limited.0.00%
Rhumbline Advisers0.00%

Corporate actions

ActionDetailDate
Split1 : 8
effective Oct 26, 2026		2026-10-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biodexa Pharmaceticals — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.